Drug resistance in amoebiasis

Devendra Bansal, Nancy Malla, R. C. Mahajan

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

Amoebiasis caused by Entamoeba histolytica, is a major public health problem in developing countries. Morphologically similar E. dispar is non pathogenic. Because of the redefinition of E. histolytica and E. dispar, and the limited number of antiamoebic drugs available, a new approach to treat such individuals is necessary. The cost of treating asymptomatic individuals is highly exorbitant and not justifiable. The indiscriminate use of antiamoebic drugs can result in increased minimum inhibitory concentration (MIC) values against Entamoeba species, and treatment failure may emerge as an important public health problem. Development of new antiamoebic drugs is still in infancy and vaccine development appears to be distant dream. In future, the development of drug resistance may seriously affect the control of disease. This review discusses the factors involved in drug resistance mechanisms developed by the parasite.

Original languageEnglish
Pages (from-to)115-118
Number of pages4
JournalIndian Journal of Medical Research
Volume123
Issue number2
Publication statusPublished - 1 Feb 2006
Externally publishedYes

Fingerprint

Amebiasis
Drug Resistance
Entamoeba histolytica
Public Health
Pharmaceutical Preparations
Entamoeba
Public health
Medical problems
Microbial Sensitivity Tests
Treatment Failure
Developing Countries
Parasites
Vaccines
Costs and Cost Analysis
Developing countries
Costs

Keywords

  • Amoebiasis
  • Emetine
  • In vitro sensitivity
  • Metronidazole
  • Multidrug resistance mechanism

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Bansal, D., Malla, N., & Mahajan, R. C. (2006). Drug resistance in amoebiasis. Indian Journal of Medical Research, 123(2), 115-118.

Drug resistance in amoebiasis. / Bansal, Devendra; Malla, Nancy; Mahajan, R. C.

In: Indian Journal of Medical Research, Vol. 123, No. 2, 01.02.2006, p. 115-118.

Research output: Contribution to journalReview article

Bansal, D, Malla, N & Mahajan, RC 2006, 'Drug resistance in amoebiasis', Indian Journal of Medical Research, vol. 123, no. 2, pp. 115-118.
Bansal D, Malla N, Mahajan RC. Drug resistance in amoebiasis. Indian Journal of Medical Research. 2006 Feb 1;123(2):115-118.
Bansal, Devendra ; Malla, Nancy ; Mahajan, R. C. / Drug resistance in amoebiasis. In: Indian Journal of Medical Research. 2006 ; Vol. 123, No. 2. pp. 115-118.
@article{d889c02f14cb4d6da7d34a95701467ea,
title = "Drug resistance in amoebiasis",
abstract = "Amoebiasis caused by Entamoeba histolytica, is a major public health problem in developing countries. Morphologically similar E. dispar is non pathogenic. Because of the redefinition of E. histolytica and E. dispar, and the limited number of antiamoebic drugs available, a new approach to treat such individuals is necessary. The cost of treating asymptomatic individuals is highly exorbitant and not justifiable. The indiscriminate use of antiamoebic drugs can result in increased minimum inhibitory concentration (MIC) values against Entamoeba species, and treatment failure may emerge as an important public health problem. Development of new antiamoebic drugs is still in infancy and vaccine development appears to be distant dream. In future, the development of drug resistance may seriously affect the control of disease. This review discusses the factors involved in drug resistance mechanisms developed by the parasite.",
keywords = "Amoebiasis, Emetine, In vitro sensitivity, Metronidazole, Multidrug resistance mechanism",
author = "Devendra Bansal and Nancy Malla and Mahajan, {R. C.}",
year = "2006",
month = "2",
day = "1",
language = "English",
volume = "123",
pages = "115--118",
journal = "Indian Journal of Medical Research",
issn = "0971-5916",
publisher = "Indian Council of Medical Research",
number = "2",

}

TY - JOUR

T1 - Drug resistance in amoebiasis

AU - Bansal, Devendra

AU - Malla, Nancy

AU - Mahajan, R. C.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Amoebiasis caused by Entamoeba histolytica, is a major public health problem in developing countries. Morphologically similar E. dispar is non pathogenic. Because of the redefinition of E. histolytica and E. dispar, and the limited number of antiamoebic drugs available, a new approach to treat such individuals is necessary. The cost of treating asymptomatic individuals is highly exorbitant and not justifiable. The indiscriminate use of antiamoebic drugs can result in increased minimum inhibitory concentration (MIC) values against Entamoeba species, and treatment failure may emerge as an important public health problem. Development of new antiamoebic drugs is still in infancy and vaccine development appears to be distant dream. In future, the development of drug resistance may seriously affect the control of disease. This review discusses the factors involved in drug resistance mechanisms developed by the parasite.

AB - Amoebiasis caused by Entamoeba histolytica, is a major public health problem in developing countries. Morphologically similar E. dispar is non pathogenic. Because of the redefinition of E. histolytica and E. dispar, and the limited number of antiamoebic drugs available, a new approach to treat such individuals is necessary. The cost of treating asymptomatic individuals is highly exorbitant and not justifiable. The indiscriminate use of antiamoebic drugs can result in increased minimum inhibitory concentration (MIC) values against Entamoeba species, and treatment failure may emerge as an important public health problem. Development of new antiamoebic drugs is still in infancy and vaccine development appears to be distant dream. In future, the development of drug resistance may seriously affect the control of disease. This review discusses the factors involved in drug resistance mechanisms developed by the parasite.

KW - Amoebiasis

KW - Emetine

KW - In vitro sensitivity

KW - Metronidazole

KW - Multidrug resistance mechanism

UR - http://www.scopus.com/inward/record.url?scp=33645474210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645474210&partnerID=8YFLogxK

M3 - Review article

C2 - 16575108

AN - SCOPUS:33645474210

VL - 123

SP - 115

EP - 118

JO - Indian Journal of Medical Research

JF - Indian Journal of Medical Research

SN - 0971-5916

IS - 2

ER -